• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

每个化学基因组学文库的多药药理学程度如何?

How polypharmacologic is each chemogenomics library?

作者信息

Ni Eric, Kwon Eehjoe, Young Lauren M, Felsovalyi Klara, Fuller Jennifer, Cardozo Timothy

机构信息

NYU Langone Health, Department of Biochemistry & Molecular Pharmacology, New York, NY 10016, USA.

Genecentrix Inc, New York, NY 10014, USA.

出版信息

Future Drug Discov. 2020 Feb 5;2(1):FDD26. doi: 10.4155/fdd-2019-0032.

DOI:10.4155/fdd-2019-0032
PMID:32149277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7052528/
Abstract

AIM

High-throughput phenotypic screens have emerged as a promising avenue for small-molecule drug discovery. The challenge faced in high-throughput phenotypic screens is target deconvolution once a small molecule hit is identified. Chemogenomics libraries have emerged as an important tool for meeting this challenge. Here, we investigate their target-specificity by deriving a 'polypharmacology index' for broad chemogenomics screening libraries.

METHODS

All known targets of all the compounds in each library were plotted as a histogram and fitted to a Boltzmann distribution, whose linearized slope is indicative of the overall polypharmacology of the library.

RESULTS & CONCLUSION: Comparison of libraries clearly distinguished the most target-specific library, which might be assumed to be more useful for target deconvolution in a phenotypic screen.

摘要

目的

高通量表型筛选已成为小分子药物发现的一条有前景的途径。高通量表型筛选面临的挑战是一旦鉴定出小分子活性物质,就要进行靶点反卷积。化学基因组学文库已成为应对这一挑战的重要工具。在此,我们通过为广泛的化学基因组学筛选文库推导一个“多药理学指数”来研究它们的靶点特异性。

方法

将每个文库中所有化合物的所有已知靶点绘制成直方图,并拟合到玻尔兹曼分布,其线性化斜率表明文库的整体多药理学特性。

结果与结论

文库之间的比较清楚地区分出了靶点特异性最强的文库,该文库可能被认为在表型筛选中对靶点反卷积更有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b96/7052528/604a1d51b551/fdd-02-26-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b96/7052528/91d7014bffcf/fdd-02-26-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b96/7052528/4d3351cb0648/fdd-02-26-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b96/7052528/8f6569fae037/fdd-02-26-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b96/7052528/604a1d51b551/fdd-02-26-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b96/7052528/91d7014bffcf/fdd-02-26-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b96/7052528/4d3351cb0648/fdd-02-26-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b96/7052528/8f6569fae037/fdd-02-26-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b96/7052528/604a1d51b551/fdd-02-26-g4.jpg

相似文献

1
How polypharmacologic is each chemogenomics library?每个化学基因组学文库的多药药理学程度如何?
Future Drug Discov. 2020 Feb 5;2(1):FDD26. doi: 10.4155/fdd-2019-0032.
2
Development of a chemogenomics library for phenotypic screening.用于表型筛选的化学基因组学文库的开发。
J Cheminform. 2021 Nov 24;13(1):91. doi: 10.1186/s13321-021-00569-1.
3
An Introduction to Chemogenomics.化学生物基因组学简介。
Methods Mol Biol. 2023;2706:1-10. doi: 10.1007/978-1-0716-3397-7_1.
4
Chemogenomics approaches to novel target discovery.用于新靶点发现的化学基因组学方法。
Expert Rev Proteomics. 2007 Jun;4(3):411-9. doi: 10.1586/14789450.4.3.411.
5
The Role of Historical Bioactivity Data in the Deconvolution of Phenotypic Screens.历史生物活性数据在表型筛选反卷积中的作用。
J Biomol Screen. 2014 Jun;19(5):696-706. doi: 10.1177/1087057113518966. Epub 2014 Jan 17.
6
The Future of Computational Chemogenomics.计算化学基因组学的未来
Methods Mol Biol. 2018;1825:425-450. doi: 10.1007/978-1-4939-8639-2_15.
7
Probing the chemical-biological relationship space with the Drug Target Explorer.使用药物靶点探索器探究化学-生物学关系空间。
J Cheminform. 2018 Aug 20;10(1):41. doi: 10.1186/s13321-018-0297-4.
8
Shifting from the single to the multitarget paradigm in drug discovery.从单靶点到多靶点药物研发的转变。
Drug Discov Today. 2013 May;18(9-10):495-501. doi: 10.1016/j.drudis.2013.01.008. Epub 2013 Jan 20.
9
Modeling Polypharmacological Profiles by Affinity Fingerprinting.通过亲和力指纹图谱对多药理学特征进行建模。
Curr Pharm Des. 2016;22(46):6885-6894. doi: 10.2174/1381612822666160831104718.
10
Poisson Statistics of Combinatorial Library Sampling Predict False Discovery Rates of Screening.组合文库筛选的泊松统计预测筛选的错误发现率。
ACS Comb Sci. 2017 Aug 14;19(8):524-532. doi: 10.1021/acscombsci.7b00061. Epub 2017 Jul 26.

引用本文的文献

1
Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicity.基于协同毒性的多组分、时程筛选开发联合癌症疗法。
Proc Natl Acad Sci U S A. 2024 Dec 3;121(49):e2413372121. doi: 10.1073/pnas.2413372121. Epub 2024 Nov 25.
2
Development of a chemogenomics library for phenotypic screening.用于表型筛选的化学基因组学文库的开发。
J Cheminform. 2021 Nov 24;13(1):91. doi: 10.1186/s13321-021-00569-1.

本文引用的文献

1
Cheminformatics Tools for Analyzing and Designing Optimized Small-Molecule Collections and Libraries.用于分析和设计优化的小分子集合和库的 cheminformatics 工具。
Cell Chem Biol. 2019 May 16;26(5):765-777.e3. doi: 10.1016/j.chembiol.2019.02.018. Epub 2019 Apr 4.
2
DrugBank 5.0: a major update to the DrugBank database for 2018.DrugBank 5.0:2018 年 DrugBank 数据库的重大更新。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037.
3
Applications of chemogenomic library screening in drug discovery.
化学基因组文库筛选在药物发现中的应用。
Nat Rev Drug Discov. 2017 Apr;16(4):285-296. doi: 10.1038/nrd.2016.244. Epub 2017 Jan 20.
4
Historeceptomic Fingerprints for Drug-Like Compounds.类药物化合物的组织受体组学指纹图谱。
Front Physiol. 2015 Dec 18;6:371. doi: 10.3389/fphys.2015.00371. eCollection 2015.
5
Identifying compound efficacy targets in phenotypic drug discovery.在表型药物发现中鉴定化合物疗效靶点。
Drug Discov Today. 2016 Jan;21(1):82-89. doi: 10.1016/j.drudis.2015.08.001. Epub 2015 Aug 10.
6
Developing predictive assays: the phenotypic screening "rule of 3".开发预测性检测方法:表型筛选的“3R 法则”。
Sci Transl Med. 2015 Jun 24;7(293):293ps15. doi: 10.1126/scitranslmed.aab1201.
7
Exploiting polypharmacology for drug target deconvolution.利用多药理学进行药物靶点去卷积。
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):5048-53. doi: 10.1073/pnas.1403080111. Epub 2014 Mar 19.
8
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells.高通量组合筛选鉴定出与伊布替尼协同作用杀伤激活 B 细胞样弥漫大 B 细胞淋巴瘤细胞的药物。
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2349-54. doi: 10.1073/pnas.1311846111. Epub 2014 Jan 27.
9
Identification of potent Yes1 kinase inhibitors using a library screening approach.利用文库筛选方法鉴定有效的 Yes1 激酶抑制剂。
Bioorg Med Chem Lett. 2013 Aug 1;23(15):4398-403. doi: 10.1016/j.bmcl.2013.05.072. Epub 2013 May 29.
10
Target deconvolution techniques in modern phenotypic profiling.现代表型分析中的靶标去卷积技术。
Curr Opin Chem Biol. 2013 Feb;17(1):118-26. doi: 10.1016/j.cbpa.2012.12.022. Epub 2013 Jan 18.